Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.

NCT ID: NCT04946877

Last Updated: 2022-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-01

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Determine the frequency of psychiatric and neurological comorbidities in children and adolescence diagnosed with ADHD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ADHD is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and inattention .ADHD is more often a complex disorder with a high rate of associated co-morbid conditions. Co-morbid conditions are prevalent among people with ADHD and increase its burden and complexity of management.Children with ADHD are at a higher risk than children without ADHD for developing other psychiatric disorders .Motor skill problems and Neurological soft signs are found in many neuropsychiatric conditions .NSS have been associated with inattention and behaviour difficulties for decades. Some researchers argue that these signs should be included in the diagnosis of ADHD .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

case group

100 ADHD patients; will be taken from outpatient clinic of child and adolescence psychiatry of Assiut university hospitals.

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)

Intervention Type DIAGNOSTIC_TEST

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .

control group

100 normal children; they will be selected from neurology clinic complaining from minor neurological complaint e.g : headache, will match with the case group for age, sex and educational level.

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)

Intervention Type DIAGNOSTIC_TEST

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III)

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid) Child behavior checklist (CBCL), parent form Neurological assessment using Cambridge neurological inventory

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 6-17 years.
* Sex: both sexes will be included in the study.
* IQ≥70.

Exclusion Criteria

* Age: less than 6 years or more than 17 years.
* IQ\<70.
* Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy.
* Patients with major psychiatric disorders e.g schizophrenia spectrum disorder.
* Patient who refusing to participate in the study or their caregiver refusing to give informed consent.
Minimum Eligible Age

6 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salma Mohmed

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

salma mohmed fahmi, msc

Role: CONTACT

01067151755

Ahmed Abdelbaky Abd elrahman, MD

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rastam M, Johnson M, Rothenberger A, Niklasson L. Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I80-92. doi: 10.1007/s00787-004-1008-4.

Reference Type BACKGROUND
PMID: 15322959 (View on PubMed)

Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Aug 6;1:15020. doi: 10.1038/nrdp.2015.20.

Reference Type BACKGROUND
PMID: 27189265 (View on PubMed)

Jensen CM, Steinhausen HC. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38. doi: 10.1007/s12402-014-0142-1. Epub 2014 Jun 19.

Reference Type BACKGROUND
PMID: 24942707 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Comorbidities with ADHD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevalence of ADHD in Children With Epilepsy
NCT07205211 NOT_YET_RECRUITING
rTMS in Children and Adolescents With ADHD:
NCT06389864 NOT_YET_RECRUITING NA